rs61749713

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001110792.2(MECP2):ā€‹c.623C>Gā€‹(p.Thr208Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000503 in 1,209,778 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 192 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.00030 ( 0 hom., 5 hem., cov: 23)
Exomes š‘“: 0.00052 ( 0 hom. 187 hem. )

Consequence

MECP2
NM_001110792.2 missense

Scores

1
1
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 0.666
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0648078).
BP6
Variant X-154031241-G-C is Benign according to our data. Variant chrX-154031241-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 143627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154031241-G-C is described in Lovd as [Likely_benign]. Variant chrX-154031241-G-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.000524 (575/1098255) while in subpopulation NFE AF= 0.000609 (513/842137). AF 95% confidence interval is 0.000565. There are 0 homozygotes in gnomad4_exome. There are 187 alleles in male gnomad4_exome subpopulation. Median coverage is 35. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MECP2NM_001110792.2 linkuse as main transcriptc.623C>G p.Thr208Ser missense_variant 3/3 ENST00000453960.7 NP_001104262.1
MECP2NM_004992.4 linkuse as main transcriptc.587C>G p.Thr196Ser missense_variant 4/4 ENST00000303391.11 NP_004983.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkuse as main transcriptc.623C>G p.Thr208Ser missense_variant 3/31 NM_001110792.2 ENSP00000395535 P51608-2
MECP2ENST00000303391.11 linkuse as main transcriptc.587C>G p.Thr196Ser missense_variant 4/41 NM_004992.4 ENSP00000301948 P1P51608-1

Frequencies

GnomAD3 genomes
AF:
0.000305
AC:
34
AN:
111523
Hom.:
0
Cov.:
23
AF XY:
0.000148
AC XY:
5
AN XY:
33721
show subpopulations
Gnomad AFR
AF:
0.000196
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000497
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000472
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000387
AC:
71
AN:
183378
Hom.:
0
AF XY:
0.000339
AC XY:
23
AN XY:
67852
show subpopulations
Gnomad AFR exome
AF:
0.0000760
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00131
Gnomad NFE exome
AF:
0.000562
Gnomad OTH exome
AF:
0.000663
GnomAD4 exome
AF:
0.000524
AC:
575
AN:
1098255
Hom.:
0
Cov.:
35
AF XY:
0.000514
AC XY:
187
AN XY:
363609
show subpopulations
Gnomad4 AFR exome
AF:
0.0000379
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000369
Gnomad4 FIN exome
AF:
0.00123
Gnomad4 NFE exome
AF:
0.000609
Gnomad4 OTH exome
AF:
0.000195
GnomAD4 genome
AF:
0.000305
AC:
34
AN:
111523
Hom.:
0
Cov.:
23
AF XY:
0.000148
AC XY:
5
AN XY:
33721
show subpopulations
Gnomad4 AFR
AF:
0.000196
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000497
Gnomad4 NFE
AF:
0.000472
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000473
Hom.:
4
Bravo
AF:
0.000253
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.000743
AC:
5
ExAC
AF:
0.000395
AC:
48
EpiCase
AF:
0.000436
EpiControl
AF:
0.000415

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 08, 2015- -
Benign, no assertion criteria providedcurationRettBASEMar 29, 2011- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2013- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
not provided Benign:5
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2023MECP2: BP4, BS2 -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 08, 2018This variant is associated with the following publications: (PMID: 17387578, 12111644, 15211631) -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Rett syndrome Benign:2
Benign, criteria provided, single submittercurationCentre for Population Genomics, CPGMar 08, 2024This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Severe neonatal-onset encephalopathy with microcephaly Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 21, 2024- -
Rett syndrome;C0796222:X-linked intellectual disability-psychosis-macroorchidism syndrome;C1845336:Autism, susceptibility to, X-linked 3;C1846058:Syndromic X-linked intellectual disability Lubs type;C1968556:Severe neonatal-onset encephalopathy with microcephaly Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 20, 2021- -
History of neurodevelopmental disorder Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 08, 2017This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
MECP2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 26, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
11
DANN
Benign
0.58
DEOGEN2
Benign
0.076
T;T
FATHMM_MKL
Benign
0.31
N
LIST_S2
Benign
0.34
T;T
M_CAP
Pathogenic
0.39
D
MetaRNN
Benign
0.065
T;T
MetaSVM
Benign
-0.81
T
MutationTaster
Benign
1.0
N;N;N
REVEL
Benign
0.19
Sift4G
Benign
0.30
T;T
Vest4
0.26
MVP
0.94
ClinPred
0.00088
T
GERP RS
1.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61749713; hg19: chrX-153296692; COSMIC: COSV99066738; COSMIC: COSV99066738; API